Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-005972

Options or other derivatives

  • Chief Business Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Robb Gary Charles Chief Business Officer 2022-02-02 Grant or award · Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X03/doc4.xml…